Edmonton, Alberta, December 11, 2024 – The Owl River Métis Community Association and Culture Pathway Development Corp. have announced a partnership aimed at launching a renewable energy project. This initiative is expected to significantly impact the community and create new opportunities. A press conference is scheduled for December 16, 2024, where further details will be disclosed.
Research Update on Cancer Treatment – Io Therapeutics, Inc. has presented findings from studies involving its RAR gamma agonist compound, IRX5010. The research focuses on treating a mouse model of triple-negative breast cancer, showcasing the compound's effectiveness when combined with an anti-PDL-1 monoclonal antibody checkpoint inhibitor.